Technical Analysis for AZNCF - Astrazeneca Plc Ord

Grade Last Price % Change Price Change
grade A 85.61 0.53% 0.4545
AZNCF closed up 0.53 percent on Monday, September 16, 2019, on 8 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical AZNCF trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Strong but Oversold Other 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.53%
Gapped Down Weakness 0.53%
Fell Below 20 DMA Bearish -0.11%
MACD Bearish Signal Line Cross Bearish -0.11%

Older signals for AZNCF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
AstraZeneca PLC discovers, develops, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, gastrointestinal, neuroscience, and infection diseases worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL4, Tenormin5, and Zestril6 for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo4 for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a strategic partnership with Bicycle Therapeutics; and with Biothera Pharmaceuticals, Inc. to evaluate cancer related drugs, as well as has a collaboration agreement with Innate Pharma S.A. for oncology development. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC has clinical collaboration with Immunomedics, Inc. for the development of Imfinzi(R) and sacituzumab govitecan combination therapy, to include second-line metastatic non-small cell lung cancer. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Chemistry Cancer Chemical Compounds Organic Compounds Neuroscience Metabolic Diseases Cardiovascular Diseases Respiratory Diseases Chloroarenes Astrazeneca Bristol Myers Squibb Gastrointestinal Diseases
Is AZNCF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 90.59
52 Week Low 56.2
Average Volume 3,659
200-Day Moving Average 75.6691
50-Day Moving Average 82.271
20-Day Moving Average 87.0103
10-Day Moving Average 88.1303
Average True Range 1.4416
ADX 16.12
+DI 42.9897
-DI 49.3303
Chandelier Exit (Long, 3 ATRs ) 86.2652
Chandelier Exit (Short, 3 ATRs ) 84.0748
Upper Bollinger Band 92.4848
Lower Bollinger Band 81.5358
Percent B (%b) 0.37
BandWidth 12.583568
MACD Line 1.3547
MACD Signal Line 1.9375
MACD Histogram -0.5828
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 86.3188
Resistance 3 (R3) 86.2400 85.9250 86.2006
Resistance 2 (R2) 85.9250 85.7445 85.9644 86.1612
Resistance 1 (R1) 85.7675 85.6330 85.8463 85.8463 86.1219
Pivot Point 85.4525 85.4525 85.4919 85.4919 85.4525
Support 1 (S1) 85.2950 85.2720 85.3738 85.3738 85.0981
Support 2 (S2) 84.9800 85.1605 85.0194 85.0588
Support 3 (S3) 84.8225 84.9800 85.0194
Support 4 (S4) 84.9013